MDXH · MDxHealth SA · Metrics
$0.19
-0.01 (-2.54%)
At close · Oct 28
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$18.80M
Shares
95.42M
Volume · Oct 28
1.54M
Avg daily vol (3M)
6.08M
MDXH metrics
52 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$0.19
Market cap
$18.80M
Price action
20 metricsPrice change (1W)
+1.3%
Price change (30D)
-64.1%
Price change (3M)
-52.1%
Price change (6M)
-90.3%
Price change (YTD)
-94.5%
Price change (1Y)
-95.9%
Trailing year
Price change (5Y)
—
52-week high
$5.00
52-week low
$0.18
Change from 52-week high
-96.1%
Change from 52-week low
+7.5%
Annualized volatility
132.0%
Annualized volatility (3M)
212.7%
Beta
2.0
RSI (14D)
24.5
Price vs SMA 50
-66.3%
Price vs SMA 200
-87.5%
Avg volume (3M)
6.06M
Relative volume
0.1
Average dollar volume
$4.52M
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
95.42M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
2026-11-12
Last earnings
2026-08-13
Profitability
9 metricsGross margin
64.5%
Operating margin
-13.4%
Trailing 12 months
Net margin
-31.1%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+19.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.8%
Year over year · more shares
Revenue CAGR (3Y)
+42.8%
Revenue CAGR (5Y)
+42.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-22.7%
Debt / equity
—
Current ratio
1.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$29.03M
Total assets
$147.95M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
26
13F filer change QoQ
-26
Institutional ownership
17.4%
Conviction holders (share of 13F filers)
3.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-39.2%
Holder tenure
9.6
Price vs estimated holder cost
-84.5%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
1.2%
Latest settlement · 4.9 days to cover
Days to cover
4.9d
Short-squeeze score
43 / 100
Insider activity
2 metricsNet insider buying (90D)
$1,000,000
Insider-sentiment score
89 / 100
Risk flags
1 metricsGoing concern
—